Analyst Ratings for Better Therapeutics (BTTX)
BTTX Rating Summary
BTTX Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$16.00 (+846.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Avg. $ Target:
$16.00 (+846.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/28/2021 | LifeSci Capital | Rahul Rakhit | New Coverage | Outperform (N/A) |
15.00 (N/A) |
5.39 (1.69) |
-68.65% | Details |
| 11/24/2021 | Chardan Capital Markets | Keay Naka | New Coverage | Buy (N/A) |
17.00 (N/A) |
6.41 (1.69) |
-73.63% | Details |
 |
||||||||
